SUPERNUS PHARMACEUTICALS INC
SUPN · NASDAQ
Updated at 2026-10-15 10:24:45
- Today's High
- $43.26
- Today’s Low
- $39.97
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $41.93
- Previous Close
- $40.18
- Volume
- 810.41K
- Market Cap
- $2.33B
- P/E Ratio
- --
- EPS
- $-1.91
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, UNITED STATES, 20850
- Country
- US
- Listing Date
- 2010-12-28
- Fiscal Year End
- December
- Shares Outstanding
- 58.04M
- CIK
- 0001356576
- Website
- www.supernus.com
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of diseases of the central nervous system in the United States. The company is headquartered in Rockville, Maryland.
Financial Metrics
Revenue
2026-06-30
$219.05M
2026-03-31
$207.7M
2025-12-31
$211.57M
2025-09-30
$192.1M
Operating Expenses
2026-06-30
$243.35M
2026-03-31
$192.64M
2025-12-31
$174.74M
2025-09-30
$233.36M
Net Income
2026-06-30
-$58.37M
2026-03-31
-$2.29M
2025-12-31
-$4.1M
2025-09-30
-$45.11M
Net Profit Margin
2026-06-30
-26.64%
2026-03-31
-1.1%
2025-12-31
-1.94%
2025-09-30
-23.48%
Earnings Per Share
2026-06-30
$0.39
2026-03-31
$0.21
2025-12-31
$0.88
2025-09-30
$0.61
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$29.58M
2026-03-31
$20.19M
2025-12-31
$26.67M
2025-09-30
-$33.14M
Effective Tax Rate
2026-06-30
-1.25%
2026-03-31
61.46%
2025-12-31
-114.47%
2025-09-30
22.15%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $219.05M | $207.7M | $211.57M | $192.1M |
| Operating Expenses | $243.35M | $192.64M | $174.74M | $233.36M |
| Net Income | -$58.37M | -$2.29M | -$4.1M | -$45.11M |
| Net Profit Margin | -26.64% | -1.1% | -1.94% | -23.48% |
| Earnings Per Share | $0.39 | $0.21 | $0.88 | $0.61 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$29.58M | $20.19M | $26.67M | -$33.14M |
| Effective Tax Rate | -1.25% | 61.46% | -114.47% | 22.15% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.